0001628280-23-041230.txt : 20231211 0001628280-23-041230.hdr.sgml : 20231211 20231211160951 ACCESSION NUMBER: 0001628280-23-041230 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230901 FILED AS OF DATE: 20231211 DATE AS OF CHANGE: 20231211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chadha Deepak CENTRAL INDEX KEY: 0001784380 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21088 FILM NUMBER: 231478221 MAIL ADDRESS: STREET 1: 5777 CENTRAL AVENUE, SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fresh Tracks Therapeutics, Inc. CENTRAL INDEX KEY: 0000819050 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 930948554 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (720) 505-4755 MAIL ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Brickell Biotech, Inc. DATE OF NAME CHANGE: 20190830 FORMER COMPANY: FORMER CONFORMED NAME: VICAL INC DATE OF NAME CHANGE: 19940211 4 1 wk-form4_1702328981.xml FORM 4 X0508 4 2023-09-01 1 0000819050 Fresh Tracks Therapeutics, Inc. FRTX 0001784380 Chadha Deepak C/O FRESH TRACKS THERAPEUTICS, INC. 200 CENTRAL AVENUE, SUITE 100 BOULDER CO 80301 0 1 0 0 Former Chief R&D Officer & COO 0 Common Stock 2023-09-01 4 M 0 35000 A 37292 D Common Stock 2023-09-01 4 F 0 14978 0.621 D 22314 D Restricted Stock Units 2023-09-01 4 M 0 35000 0 D Common Stock 35000 0 D The restricted stock units were granted on January 24, 2023 and were subject to accelerated vesting as of the date of the reporting person's termination pursuant to his employment agreement with the issuer. Each restricted stock unit converted into common stock on a one-for-one basis. On July 5, 2022, the registrant effected a 1-for-45 reverse stock split ("Reverse Stock Split") of its common stock. The number of shares beneficially owned has been adjusted to give effect to the Reverse Stock Split. This balance includes 555 shares purchased under the Fresh Tracks Therapeutics, Inc. Employee Stock Purchase Plan that were not previously reported. Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units. The restricted stock units vested in full on September 1, 2023. /s/ Griffin D. Foster, Attorney-in-Fact for Deepak Chadha (power of attorney previously filed) 2023-12-11